BlackRock’s Vascular Solutions Inc VASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,360
Closed -$76K 5134
2016
Q4
$76K Hold
1,360
﹤0.01% 2725
2016
Q3
$66K Buy
1,360
+177
+15% +$8.24K ﹤0.01% 2836
2016
Q2
$49K Hold
1,183
﹤0.01% 2945
2016
Q1
$39K Buy
1,183
+606
+105% +$17.5K ﹤0.01% 2508
2015
Q4
$20K Buy
577
+183
+46% +$6.2K ﹤0.01% 2599
2015
Q3
$13K Hold
394
﹤0.01% 2629
2015
Q2
$14K Sell
394
-43
-10% -$1.4K ﹤0.01% 2608
2015
Q1
$13K Hold
437
﹤0.01% 2608
2014
Q4
$12K Hold
437
﹤0.01% 2682
2014
Q3
$11K Hold
437
﹤0.01% 2701
2014
Q2
$10K Sell
437
-69
-14% -$1.51K ﹤0.01% 2822
2014
Q1
$13K Hold
506
﹤0.01% 2586
2013
Q4
$12K Hold
506
﹤0.01% 2637
2013
Q3
$9K Hold
506
﹤0.01% 2740
2013
Q2
$7K Buy
+506
New +$7.96K ﹤0.01% 2909

Other funds holding VASC

BlackRock's VASC Position: Q1 2017 in Review

BlackRock sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 1,360 shares — an estimated $76K sold.

BlackRock first reported a position in VASC in Q2 2013 and held it in 15 quarters. The position peaked at $76K in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • BlackRock reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • BlackRock sold 1,360 Vascular Solutions Inc shares in Q1 2017, an estimated $76K.
  • BlackRock first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 15 quarters.
  • BlackRock's Vascular Solutions Inc position peaked at $76K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on BlackRock's 13F filing for Q1 2017, filed 12 May 2017.